HER2-Positive Gastric Cancer

被引：0
|
作者：
Haralabos Demetriades
机构：
[1] Aristotle University of Thessaloniki,4th Surgical Department
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Gastric Cancer; Trastuzumab; Gastric Cancer Patient; Adjuvant Setting; HER2 Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：1
相关论文
共 50 条
  • [21] HER2-positive gastric cancer identified by serum HER2: A case report
    Saito, Mayuko
    Kawakami, Yujiro
    Yamashita, Kentaro
    Nasuno, Hiroshi
    Ishimine, Yu
    Fukuda, Koichiro
    Isshiki, Hiroyuki
    Suzuki, Ryo
    Arimura, Yoshiaki
    Shinomura, Yasuhisa
    ONCOLOGY LETTERS, 2016, 11 (06) : 3575 - 3578
  • [22] Clinicopathological features and endoscopic findings of HER2-positive gastric cancer
    Oono, Yasuhiro
    Kuwata, Takeshi
    Takashima, Kenji
    Yoda, Yusuke
    Ikematsu, Hiroaki
    Shitara, Kohei
    Kinoshita, Takahiro
    Yano, Tomonori
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (09): : 3964 - 3971
  • [23] Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Takahashi, Yuta
    Kurihara, Eisuke
    Namba, Kei
    Ogoshi, Yusuke
    Torigoe, Hidejiro
    Sato, Hiroki
    Yamamoto, Hiromasa
    Soh, Junichi
    Fujiwara, Toshiyoshi
    Toyooka, Shinichi
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Clinicopathological features and endoscopic findings of HER2-positive gastric cancer
    Yasuhiro Oono
    Takeshi Kuwata
    Kenji Takashima
    Yusuke Yoda
    Hiroaki Ikematsu
    Kohei Shitara
    Takahiro Kinoshita
    Tomonori Yano
    Surgical Endoscopy, 2018, 32 : 3964 - 3971
  • [25] Resistance mechanisms to HER2-targeting treatment in HER2-positive gastric cancer
    Kang, Kyo Hwa
    Nam, Ah-Rong
    Park, Ji Eun
    Bang, Ju-Hee
    Ling, Jin
    Jin, Mei Hua
    Kim, Tae Yong
    Han, Sae-Won
    Song, Sang-Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER RESEARCH, 2015, 75
  • [26] Herceptin in metastatic HER2-positive gastric cancer - GEJ approved
    Jelitto, H. -U.
    VISZERALMEDIZIN, 2010, 26 (02): : 141 - 141
  • [27] Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
    Shitara, Kohei
    Bang, Yung-Jue
    Iwasa, Satoru
    Sugimoto, Naotoshi
    Ryu, Min-Hee
    Sakai, Daisuke
    Chung, Hyun-Cheol
    Kawakami, Hisato
    Yabusaki, Hiroshi
    Lee, Jeeyun
    Saito, Kaku
    Kawaguchi, Yoshinori
    Kamio, Takahiro
    Kojima, Akihito
    Sugihara, Masahiro
    Yamaguchi, Kensei
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25): : 2419 - 2430
  • [28] Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
    Kotani, Daisuke
    Shitara, Kohei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [29] Trastuzumab in HER2-Positive Metastatic Gastric Cancer Profile Report
    Croxtall, Jamie D.
    McKeage, Kate
    BIODRUGS, 2011, 25 (04) : 257 - 259
  • [30] SECOND-LINE TREATMENT OF HER2-POSITIVE GASTRIC CANCER
    Hamamoto, Y.
    Funakoshi, S.
    Higuchi, H.
    Takaishi, H.
    Hibi, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
12345